Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.48 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | G6PD | P11413 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | BLK | P51451 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29413052 | 1.00 | CD44 (0.48) | CD44BRPF1MYCALDH1A1HPGD | |
| Methoxymethane SCHEMBL27859974 | 0.94 | CD44 (0.43) | CD44BRPF1MYCALDH1A1HPGD | |
| SCHEMBL3498784 | 0.86 | G6PD (0.46) | BRPF1MYCALDH1A1HPGDKDM4E | |
| SCHEMBL2212474 | 0.84 | CD44 (0.50) | CD44MYCALDH1A1HPGDKDM4E | |
| SCHEMBL158431 | 0.83 | CD44 (0.48) | CD44MYCALDH1A1HPGDKDM4E | |
| SCHEMBL29442190 | 0.83 | CD44 (0.48) | CD44MYCALDH1A1HPGDKDM4E | |
| SCHEMBL130355 | 0.83 | KDM4E (0.61) | CD44MYCALDH1A1HPGDKDM4E | |
| SCHEMBL29367017 | 0.83 | KDM4E (0.61) | CD44MYCALDH1A1HPGDKDM4E | |
| Benzene SCHEMBL28094805 | 0.83 | KDM4E (0.61) | CD44MYCALDH1A1HPGDKDM4E | |
| Acetic Acid SCHEMBL28650474 | 0.82 | MYC (0.46) | CD44MYCALDH1A1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105648440-B | Liquid composition and the engraving method for using it | 三菱瓦斯化学株式会社 | 2019-10-25 | — | — | CN | claimed |
| US-20240197729-A1 | ALK-5 Inhibitors and Uses Thereof | SUMITOMO PHARMA ONCOLOGY INC (US) | 2024-06-20 | — | — | US | disclosed |
| EP-4313052-A1 | ALK-5 INHIBITORS AND USES THEREOF | Sumitomo Pharma Oncology, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117355304-A | ALK-5 inhibitors and uses thereof | 住友制药肿瘤公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20230339844-A1 | A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD. (IN) | 2023-10-26 | — | — | US | disclosed |
| US-20230339844-A1 | A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD. (IN) | 2023-10-26 | — | — | US | disclosed |
| US-20230339844-A1 | A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD. (IN) | 2023-10-26 | — | — | US | disclosed |
| EP-4259145-A1 | ALK-5 INHIBITORS AND USES THEREOF | Sumitomo Pharma Oncology, Inc. (US) | 2023-10-18 | — | — | EP | disclosed |
| US-11746103-B2 | ALK-5 inhibitors and uses thereof | SUMITOMO PHARMA ONCOLOGY, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| US-11746103-B2 | ALK-5 inhibitors and uses thereof | SUMITOMO PHARMA ONCOLOGY, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| US-6291452-B1 | CHOLECYSTOKININ ANTAGONISTS. | FUJISAWA PHARMACETICAL CO., LTD. (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-0934282-A1 | 1,4-BENZODIAZEPINONES AND THEIR USES AS CCK ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |
| CN-1189763-A | Herbicidal compositions comprising 4-iodo-2- [ 3- (4-methoxy-6-methyl-1, 3, 5-triazin-2-yl) ureidosulfonyl ] benzoates | HOECHST SCHERING AGREVO GMBH (DE) | 1998-08-05 | — | — | CN | disclosed |
| WO-1998015535-A1 | 1,4-BENZODIAZEPINONES AND THEIR USES AS CCK ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-04-16 | — | — | WO | disclosed |
| WO-1997040026-A1 | SUBSTITUTED SULFONYLAMINO(THIO)CARBONYLTRIAZOLIN(THI)ONES AND THEIR USE AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-10-30 | — | — | WO | disclosed |
| US-4465502-A | Herbicidal N-haloacetyl-2-substituted-6-acylanilines | CHEVRON RESEARCH COMPANY (US) | 1984-08-14 | — | — | US | disclosed |
| US-4456471-A | PREEMERGENCE HERBICIDE FOR GRASSES | CHEVRON RESEARCH COMPANY (US) | 1984-06-26 | — | — | US | disclosed |
| US-4348222-A | Herbicidal N-haloacetyl-2-alkyl-6-acylanilines | CHEVRON RESEARCH COMPANY (US) | 1982-09-07 | — | — | US | disclosed |
| US-4244730-A | Herbicidal N-haloacetyl-2-alkyl-6-acylanilines | CHEVRON RESEARCH COMPANY (US) | 1981-01-13 | — | — | US | disclosed |
| US-4032573-A | ANESTHETIC, ANTIARRYTHMIA | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240197729-A1 | ALK-5 Inhibitors and Uses Thereof | ACVR1, ALK, ACVRL1 | CD44 2911/4885BRPF1 2641/4885MYC 160/4885 |
| US-20230339844-A1 | A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF | ASS1, ACMSD, ADCY10 | CD44 4850/4885BRPF1 834/4885MYC 3405/4885 |
| US-11746103-B2 | ALK-5 inhibitors and uses thereof | ACVR1, ALK, ACVRL1 | CD44 3117/4885BRPF1 3037/4885MYC 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.